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OBJECTIVE: Nitric oxide produced by endothelial nitric oxide synthase (eNOS) possesses multiple anti-atherosclerotic properties. 
Hence, enhanced expression of eNOS and increased Nitric oxide levels may protect against the development of atherosclerosis. 
Piper sarmentosum is a tropical plant with antioxidant and anti-inflammatory activities. This study aimed to investigate the effects 
of Piper sarmentosum on the eNOS and Nitric oxide pathway in cultured human umbilical vein endothelial cells (HUVECs). 
METHODS: HUVECs were divided into four groups: control, treatment with 180 μM hydrogen peroxide (H2O2), treatment with 
150 μg/mL aqueous extract of Piper sarmentosum, and concomitant treatment with aqueous extract of PS and H2O2 for 24 hours. 
Subsequently, HUVECs were harvested and eNOS mRNA expression was determined using qPCR. The eNOS protein level was 
measured using ELISA, and the eNOS activity and Nitric oxide level were determined by the Griess reaction. 
RESULTS: Human umbilical vein endothelial cells treated with aqueous extract of Piper sarmentosum showed a marked induc-
tion of Nitric oxide. Treatment with PS also resulted in increased eNOS mRNA expression, eNOS protein level and eNOS activity 
in HUVECs. 
CONCLUSION: Aqueous extract of Piper sarmentosum may improve endothelial function by promoting NO production in HUVECs. 
KEYWORDS: Piper sarmentosum, Nitric oxide, Endothelial nitric oxide synthase, Oxidative stress, Human umbilical vein en-
dothelial cells.
INTRODUCTION 
Nitric oxide (NO) in the endothelium is synthesized by 
endothelial nitric oxide synthase (eNOS) via the conversion 
of L-arginine to L-citrulline. The reaction requires 
the presence of the following cofactors: nicotinamide 
adenine dinucleotide phosphate (NADPH), calcium/
calmodulin (CaM), flavin adenine dinucleotide (FAD), flavin 
mononucleotide (FMN) and tetrahydrobiopterin (BH
4
).1,2 
Nitric oxide has been recognized as a major anti-
atherogenic factor because of its vasoprotective activity.3 
Nitric oxide induces vasorelaxation by activating soluble 
guanylate cyclase; thus, NO plays an important role in 
regulating the vascular tone. Nitric oxide has also been 
shown to inhibit oxidation of low-density lipoprotein (LDL) 
and antagonize platelet aggregation by inhibiting platelet 
activation.3 Moreover, NO inhibits nuclear factor-κB-
dependent expression of adhesion molecules that mediate 
recruitment of leukocytes to the endothelium in the early 
phase of atherosclerosis. Nitric oxide has been shown to 
suppress abnormal proliferation of vascular smooth muscle 
cells, which contribute to the narrowing of atherosclerotic 
vessel walls.3 Based on these anti-atherosclerotic properties, 
the enhancement of endothelial NO production may 
play an important role in the prophylaxis or treatment of 
cardiovascular diseases.4
Oxidative stress plays an important role in the 
pathogenesis of atherosclerosis and cardiovascular diseases 
by promoting endothelial dysfunction, inflammation and 
lipid/lipoprotein peroxidation as well as by reducing 
NO bioavailability.5 Loss of normal NO production 
from the endothelium is a cardinal feature of endothelial 
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dysfunction.6 Endothelial dysfunction is characterized 
by a reduction in the bioavailability of NO, which is 
followed by increased levels of endothelium-derived 
vasoconstrictors such as endothelin-1.7 This imbalance 
leads to impairment of endothelium-derived relaxation 
(EDR). Arteries may thereby be predisposed to increased 
vascular tone and vasospasm. Impairment of EDR was 
found in atherosclerotic vessels even before vascular 
structural changes had ensued.8
Piper sarmentosum (PS) is a creeping terrestrial 
herbaceous plant that belongs to the Piperaceae family. It 
is commonly found in the tropical and subtropical regions 
of the world, such as the Asian region. The leaves and roots 
of this plant have been used for the treatment of toothache, 
fungoid dermatitis on the feet, cough, asthma and pleurisy. 
9
 Chloroform extracts of Piper sarmentosum have the 
ability to act as an anti-malarial agent against Plasmodium 
falciparum and Plasmodium berghei.10 The aqueous extract 
of the entire plant has been reported to have hypoglycemic 
effects in experimental rats.11 Furthermore, the ethanolic 
extract of PS exerted anti-carcinogenic effects through 
an intrinsic apoptosis pathway in HepG2 cells.13 The 
aqueous extract of PS also exhibited anti-nociceptive and 
anti-inflammatory activities in vivo.14 Recent research has 
demonstrated that various extracts prepared from PS leaves 
have antioxidant and anti-tuberculous activities.12 To date, 
however, there is no direct evidence linking PS to the eNOS 
system. Based on the properties of PS extracts mentioned 
above, the present study was designed to investigate the 
effects of PS on the eNOS system and NO synthesis in 
human umbilical vein endothelial cells (HUVECs). The 
results of the present study may help in the prevention and 
treatment of atherosclerosis, which is linked to various 
cardiovascular diseases. 
MATERIALS AND METHODS 
Preparation of aqueous extract of Piper sarmentosum
Leaves of PS were collected in Sungai Buloh, Malaysia, 
and identified by a plant taxonomist from the Forest 
Research Institute of Malaysia (voucher specimen: FRI 
45870). The leaves were washed with tap water, cut into 
small pieces, sun-dried and ground into powder form. A 
10% aqueous extract of Piper sarmentosum (AEPS) was 
prepared by soaking 100 g of the powdered leaves in 900 
mL of purified water followed by incubation in a high-speed 
mixer at 80 °C for 3 hours. After cooling, the extract was 
filtered using mesh and further concentrated. The aqueous 
extract was then freeze-dried to powdered form and kept at 
4 °C until the experiments. 
Cell culture and treatment protocols
Human umbilical vein endothelial cells were obtained 
from umbilical cord veins using 0.1 % type I collagenase 
(Gibco-Invitrogen Corp., Grand Island, N.Y.) digestion. 
Cells were grown in medium-200 (Cascade Biologics, USA) 
supplemented with LSGS (low-serum growth supplement; 
Cascade Biologics, USA) at 37 0C in a humidified 
atmosphere of 5% CO2 and 95% air. Human umbilical vein 
endothelial cells were identified by the typical endothelial 
cell cobblestone morphology and positive expression of 
vonWillebrand factor and CD31 in immunocytochemistry. 
The culture medium was changed every other day until the 
cells reached confluence. Human umbilical vein endothelial 
cells from passage 3 at 80% confluency were used for the 
experiments. The cells were divided into four groups: control 
(CTRL), treatment with 180 μM hydrogen peroxide (H2O2) 
to induce oxidative stress; treatment with 150 μg/mL AEPS, 
and concomitant treatment with 150 μg/mL AEPS and 180 
μM H2O2. All treatments were given for 24 hours. 
Quantitative reverse transcription polymerase chain re-
action (qPCR) for analysis of eNOS mRNA expression
After treatment for 24 hours, total ribonucleic acid 
(RNA) from HUVECs was extracted using TRI Reagent 
(Molecular Research Center, Cincinnati, USA) according 
to a previously published protocol.15 Polyacryl carrier 
(Molecular Research Center, Cincinnati, USA) was added 
to precipitate the total RNA. The extracted RNA pellet was 
then washed with 75% ethanol and dried prior to being 
dissolving in RNase- and DNase-free water (Invitrogen, 
Carlsbad, USA). The extracted total RNA was assessed 
for its purity and quantity using a Nanodrop ND-100 
spectrophotometer (Wilmington DE, USA) and stored at 
−80 °C. Complimentary DNA (cDNA) was synthesized 
using SuperScript III First-Strand Synthesis SuperMix 
(Invitrogen, Carlsbad, USA). A total reaction volume of 20 
μl, which consisted of 10 μl of 2X RT Reaction Mix, 2 μl 
of RT enzyme, 5 μl of total RNA and 3 μl of DEPC-treated 
water, was incubated at 25 °C for 10 minutes for primer 
annealing. The reaction was then incubated at 50 °C for 30 
minutes for reverse transcription. Finally, the reaction was 
terminated at 85 °C for 5 minutes and chilled on ice for 
1 minute, after which 1 μl of E. coli RNase H was added 
to the mixture. The cDNA was further incubated at 37 °C 
for 20 minutes and stored at −20 °C. Subsequently, qPCR 
was carried out to determine the mRNA expression level 
of eNOS. Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was used as the reference gene. Primer 3 
software (http://frodo:wi.mit.edu/cgi-bin/primer3/primer3-
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www.cgi) was used to design the primers from the NIH 
GenBank database. The following sequences were used as 
primers for eNOS [GenBank: NM_000603] and GAPDH 
[GenBank: BC020308]: CTCCAGCCCCGGTACTACTC 
(forward) and TTAGCCACGTGGAGCAGACT (reverse), 
and TCCCTGAGCTGAACGGGAAG (forward) and 
GGAGGAGTGGGTGTCGCTGT (reverse), respectively. 
The qPCR reaction was performed in a BioRad iCycler 
(Bio-Rad, USA) with 1 μl of cDNA, 5 μM of each forward 
and reverse primer and 12.5 μl of IQ SYBR Green Supermix 
(Bio-Rad, USA). The reaction profile consisted of 40 cycles 
using the following parameters: 95○C (10 seconds) and 
61○C (30 seconds). The reaction kinetics of each primer 
set and protocol were verified with the melting profile, 
and product size was further confirmed with 2% agarose 
gel electrophoresis stained with ethidium bromide (Sigma, 
St Louis, USA). The threshold cycle (CT) value was 
determined, and the relative mRNA expression of eNOS was 
calculated with the following equation: 2∆∆CT, where ∆∆CT = 
CT GAPDH - CT eNOS. 
Enzyme-linked immunosorbent assay (ELISA) for 
eNOS protein analyses
The eNOS protein level of the cultured HUVECs was 
determined using the Quantikine human eNOS ELISA kit 
(R&D Systems). Human umbilical vein endothelial cells 
were washed twice with phosphate-buffered saline (PBS), 
manually scraped from the culture flask and lysed with 
400 μL of lysis buffer. The assay was performed using 
100 μL of the cell lysate. The cell lysate was pipetted into 
the 96-well plate so that any eNOS that was present would 
be bound to the immobilized antibody in the plate. After 
washing away any unbound substances, eNOS conjugate 
was added to the wells. This was followed by the addition 
of substrate solution and stop solution. The optical density 
of each well was determined at 450 nm using an ELISA 
microplate reader. 
Determination of eNOS Activity
The eNOS activity was determined using a commercially 
available kit (Nitric Oxide Synthase Colorimetric Assay, 
Calbiochem, USA). The principle of this assay was based on 
the measurement of nitrite produced by eNOS in the sample 
in a timed reaction. Human umbilical vein endothelial cells 
were scraped from the culture flask, homogenized in PBS 
and centrifuged at 10,000 g for 20 minutes. Then, the cell 
lysate in the supernatant solution was filtered through a 
0.45 μm filter prior to ultracentrifugation at 100,000 g for 
15 minutes. A total of 40 μL of the cell lysate was diluted 
with 20 μL of assay buffer. Next, the samples were mixed 
with NADPH, nitrate reductase, cofactor preparation 
solution and lactate dehydrogenase (LDH). Total nitrite was 
measured at 540 nm with Griess reagents (sulfanilamide 
and naphthalene–ethylene diamine dihydrochloride). The 
concentration of nitrite in the sample was calculated using a 
standard curve. The eNOS activity was expressed as nmol of 
nitrite/min per mL of sample. 
Determination of endothelial nitric oxide production 
Production of NO by HUVECs was measured via its 
stable oxidation product, nitrite, using a commercial kit 
(BIOXYTECH Nitric Oxide Colorimetric Assay, OXIS 
Research, USA). Briefly, 50 μL of the culture medium was 
diluted with 35 μL of assay buffer and mixed with 10 μL 
of nitrate reductase and 10 μL NADH. After 20 minutes 
of incubation to convert nitrate to nitrite, total nitrite was 
measured at 540 nm with Griess reagents (sulfanilamide and 
naphthalene–ethylene diamine dihydrochloride). 
Statistical analysis
Data were tested for normality using the Kolmogorov-
Smirnov test, and all variables were normally distributed. 
Data were expressed as mean ± SEM. Statistical analyses 
between two groups were performed with Student’s paired 
t-test using SPSS version 16.0 software. Values of p < 0.05 
were considered statistically significant.
RESULTS
eNOS mRNA expression in HUVECs
Treatment of HUVECs with AEPS significantly 
enhanced eNOS mRNA expression by 2.3-fold (4.405 ± 
0.892 x 10-3) compared with the control group (1.915 ± 
0.428 x 10-3) (Figure 1). In the oxidative stress-induced 
group, HUVECs treated with H2O2 also showed a 
significantly higher (2.2-fold) level of eNOS mRNA 
expression (4.280 ± 0.760 x 10-3) compared with the control 
group. However, concomitant treatment of HUVECs with 
both AEPS and H2O2 did not result in a significant increase 
in eNOS mRNA expression (2.95 ± 0.697 x 10-3) compared 
to the control group. 
eNOS protein level in HUVECs
The aqueous extract of PS significantly increased the 
eNOS protein level by 1.4-fold (1.706 ± 0.154 x 103 pg/mL) 
compared with the control group (1.235 ± 0.170 x 103 pg/
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mL) (Figure 2), which was consistent with the changes in 
eNOS mRNA. Treatment of HUVECs with H2O2 alone also 
resulted in a significantly higher (1.3-fold) level of eNOS 
protein (1.669 ± 0.137 x 103 pg/mL) compared with the 
control group. Concomitant treatment of HUVECs with 
both AEPS and H2O2 did not result in a significant increase 
in eNOS protein level (1.549 ± 0.096 x 103 pg/mL) compared 
with the control group.
eNOS activity in HUVECs
Treatment of HUVECs with AEPS significantly 
promoted eNOS enzyme activity (5.237 ± 0.55x10-2 nmoles/
mL/min) compared with the control group (4.393 ± 0.74 
x 10-2 nmoles/mL/min) (Figure 3). In the oxidative stress-
induced group, HUVECs treated with H2O2 also showed a 
significantly higher level of eNOS enzyme activity (5.863 
± 0.57 x 10-2 nmoles/mL/min) compared with the control 
group. Concomitant treatment of HUVECs with both AEPS 
and H2O2 did not result in a significant increase in eNOS 
enzyme activity (5.228 ± 1.473 x 10-2 nmoles/mL/min) 
compared with the control group. 
Nitric oxide production in HUVECs 
The aqueous extract of PS significantly promoted NO 
production in HUVECs by 6.3-fold (15.446 ± 3.879 μM) 
compared with the control group (2.454 ± 0.799 μM) 
(Figure 4). In the oxidative stress-induced group, HUVECs 
treated with H2O2 also showed a significantly higher (1.7-
fold increase) level of NO production (4.175 ± 0.966 μM) 
compared with the control group. The greatest increase 
in NO production (17.536 ± 3.55 μM) was observed in 
HUVECs treated with both AEPS and H2O2; the level of NO 
production was significantly higher than that in the control 
and H2O2 groups. 
DISCUSSION 
Oxidative stress can contribute to the development and 
progression of atherosclerosis by promoting endothelial 
dysfunction, inflammation and lipid peroxidation, as well 
Figure 1 - eNOS mRNA expression in HUVECs.
Figure 2 - eNOS protein level in HUVECs. 
Figure 3 - eNOS activity in HUVECs. 
Figure 4 - Nitric oxide production in HUVECs. 
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as by reducing NO bioavailability.16 Based on the results of 
a previous study, we used 180 μM H2O2 to induce oxidative 
stress in HUVECs.17 This concentration of H2O2 increased 
eNOS mRNA expression, eNOS protein level and eNOS 
activity (Figure 1, 2, 3). In another study, incubation of 
bovine aortic endothelial cells with 150 μM H2O2 for 24 
hours also caused an increase in eNOS mRNA, eNOS 
protein and eNOS enzyme activity.18
The NO level was higher in the H2O2-treated group 
compared to the control group. This may have been due 
to induction of NO production by H2O2 as part of the self-
protective mechanism of the cells. The dose of H2O2 used 
in this study was not lethal to HUVECs; therefore, the cells 
were still able to increase their endogenous NO production 
after an H2O2 challenge. However, H2O2 also caused 
oxidative destruction of the synthesized NO, which explains 
why the increase in NO in the H2O2-treated group was not as 
high as in the other groups (i.e., the AEPS and the combined 
AEPS and H2O2 groups) (Figure 4).
In this study, the responses to H2O2 are in agreement with 
earlier reports.5 The expression of eNOS in endothelial cells 
is regulated by NO through a negative feedback mechanism 
at both the transcriptional and translational levels. Hydrogen 
peroxide-derived upregulation of eNOS was mediated by 
diminished NO availability and a consequent reduction in 
the negative feedback regulatory action of NO on eNOS 
expression. This represents a compensatory protective 
mechanism of the cells to a reduction in NO availability 
induced by acute exposure to H2O2.5 Hydrogen peroxide has 
been shown to increase eNOS activity by inducing changes 
in the phosphorylation status of the enzyme. This response 
represents an attempt by the endothelial cells to maintain NO 
bioactivity under conditions of increased oxidative stress.19 
It is well recognized that NO produced by eNOS plays 
a protective role against the development of atherosclerosis 
and endothelial dysfuntion.20,21 The results of this study 
show that AEPS (150 μg/mL) significantly increased NO 
production in HUVECs (Figure 4). AEPS also induced 
increases in eNOS mRNA, protein and activity (Figure 1, 
2, 3). The higher amount of eNOS protein caused a higher 
level of eNOS activity. This resulted in an increase in NO 
production by HUVECs. The results of the present study 
suggest that AEPS may improve endothelial function by 
augmenting NO production in human endothelial cells. Thus, 
AEPS could reduce the risk of atherosclerosis.
Antioxidants are known to enhance the biological actions 
of NO by protecting NO against oxidative destruction by 
reactive oxygen species.21 AEPS has been shown to exhibit 
antioxidant properties.12 Thus, AEPS can directly protect 
NO from oxidative destruction by H2O2 (Figure 4). The 
aqueous extract of PS also promoted NO production from 
HUVECs by increasing eNOS protein synthesis and enzyme 
activity (Figure 2, 3). Therefore, both protection of NO from 
oxidative destruction and enhancement of eNOS activity by 
AEPS caused an increase in NO level. 
We observed the largest increase in NO production in 
the group that received AEPS and H2O2. Since AEPS can 
directly protect NO from oxidative destruction by H2O2, NO 
is available in the cells at a higher level. A higher level of 
NO in the cells reduced the mRNA expression and protein 
synthesis of eNOS via a negative feedback mechanism.5 
Previous phytochemical screening of PS revealed the 
presence of a variety of natural products, such as amides, 
polyphenols and flavonoids.12 Myricetin, apigenin and 
quercetin are examples of flavonoids identified in PS 
leaves.22 Quercetin improved endothelial dysfunction by 
increasing NO synthesis in HUVECs. The increase in NO 
synthesis was attributed to an enhancement of eNOS activity 
via increased calcium concentration.23 Quercetin has also 
been reported to exert endothelium-dependent vasodilatation 
of porcine aortic rings.24 Therefore, in the present study, 
the flavonoids appear to be the active constituents of AEPS 
responsible for enhancing NO production in HUVECs.
STUDY LIMITATIONS
This experiment was an in vitro study that investigated 
some fundamental biomolecular and cellular activities. 
The data suggest that AEPS could reduce the risk of 
atherosclerosis by increasing the bioavailability of NO 
to defend against oxidative stress. A clinical placebo-
controlled study may be needed before employing AEPS 
as an effective supplement. If this study were performed 
in a clinical setting, we could attempt to determine dosage, 
pharmacokinetics and pharmacodynamics of AEPS.
CONCLUSION
In summary, the present study demonstrated that AEPS 
increased eNOS mRNA expression, protein synthesis, eNOS 
activity and NO production that could protect HUVECs 
from from oxidative stress. Based on the vasoprotective and 
anti-atherosclerotic effects of endothelial NO, AEPS has the 
ability to reduce the risk of atherosclerosis. Further studies 
are needed to corroborate these findings.
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